The teams at Arcinova are experienced in the development, validation, application and technology transfer of GC (headspace or direct injection), ion chromatography, LC and UPLC based methodologies.
These activities are supported by a range of LC detector types including UV, DAD, N2 emission, radiochemical, MS (single quadrupole, triple quadrupole and accurate mass), ICP-MS, conductivity, fluorescence and CAD. In the case of GC, FID or TCD detection are available. Chromatographic services can be accessed for discrete projects or as part of integrated Arcinova services.
The identification of drug impurities or their degradation products is an integral part of the drug development process.
Linked to our expertise in chromatographic separation/isolation, on-site high field NMR, accurate mass spectrometry and synthetic capabilities, Arcinova scientists can offer a complete service for the identification and if relevant, chromatographic response factor determination, for impurities and degradation products of concern. This service can be accessed on a stand-alone basis or as part of an integrated CMC service.
MHRA SymposiumThe 2018 MHRA Symposium will be attended by John McRoberts, Head of QA.
MHRA SymposiumDates: 20th NovemberLocation: London, UK
AAPS: PharmSci360This years' PharmSci360 conference will be attended by Masha Kononov, Senior Director Emerging Biotech US.
AAPS: PharmSci360Dates: 4th - 7th NovemberLocation: Washington DC, US
Bio-Europe 2018Bio-Europe autumn conference will be attended by Nathalie Huther, Business Development Manager Europe.
Bio-Europe 2018Dates: 5th - 7th NovemberLocation: Copenhagen, Denmark